NCT02379091View on ClinicalTrials.gov

Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

PHASE2CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

December 17, 2014

Primary Completion Date

May 11, 2016

Study Completion Date

December 5, 2016

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Namilumab

Namilumab subcutaneous injection

DRUG

Placebo

Namilumab placebo-matching subcutaneous injection

DRUG

Methotrexate

Methotrexate tablets

DRUG

Folic/folinic acid

Folic/folinic acid tablets

Trial Locations (31)

Unknown

Plovdiv

Rousse

Sofia

České Budějovice

Prague

Uherské Hradiště

Zlín

Fukuoka

Iizuka-shi

Kitakyusyu-shi

Sapporo

Takarazuka-shi

Morioka

Kawasaki-shi

Kumamoto

Miyagi-gun

Nagasaki

Sasebo-shi

Hamamatsu

Nishimuro-gun

Bydgoszcz

Torun

Kazan'

Saint Petersburg

Ulyanovsk

Voronezh

Seoul

A Coruña

Seville

Romford

London

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY